Skip to main content
. 2021 Apr 13;12(8):726–739. doi: 10.18632/oncotarget.27945

Figure 3. Performance characteristic of GEM ExTra assay.

Figure 3

(A) Tumor specific positivity of GEM ExTra. (B) Violin plot of the number of clinically actionable events reported per tumor type. (C) Frequency of variant types across tumor types. (D) The thirty most common clinically actionable genes and number of variant types detected in each gene.